Emerald Investment Advisers LLC acquired a new position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) during the 2nd quarter, Holdings Channel reports. The fund acquired 59,747 shares of the company’s stock, valued at approximately $3,760,000. Other large investors have also recently added to or reduced their stakes in the company. Rockefeller Capital Management L.P. […]